Search Results

Search Results for "transvaginal mesh"

• FDA spied on own scientists
  The New York Times reports that the U.S. Food and Drug Administration conducted a wide-ranging surveillance operation against its own scientists. The agency used “spy software” designed to help employers monitor workers, and captured screen images from the government laptops of scientists as the...

• FDA called “sheriff packing a waterpistol”
  Amid evidence that Johnson & Johnson continued to sell a dangerous vaginal mesh implant for nine months after the U.S. Food and Drug Administration ordered it to stop, some observers are questioning whether federal regulatory agencies are currently able protect consumers. A Bloomberg story quote...

• Johnson & Johnson has history of ethical lapses
  Johnson & Johnson will reportedly pay a settlement in the neighborhood of $2 billion to settle federal charges that the company used illegal tactics in marketing its antipsychotic drug Risperdal. The federal probe prompting that settlement included investigations into the company’s alleged kic...

• FDA unveils plan to track medical devices
  The federal Food and Drug Administration has unveiled a plan to track high-risk medical devices. A Wall Street Journal report on the policy says that it would require the high-risk devices to carry identification numbers. Jeffrey Shuren, director of the FDA’s medical-device center, described t...

• Flawed FDA approval process results in deaths
  A recent report in Scientific American takes a look at a faulty heart device that’s been responsible for at least 20 deaths. According to the article, implantable defibrillator leads are wires that connect defibrillators – devices similar to pacemakers – to the heart. “Over the past decade, ...

• Mayo Clinic advises women about urinary incontinence
  In an article devoted to women’s urinary incontinence, Mayo Clinic staff members acknowledge that talking about bladder control problems is difficult. But the article urges women who experience bladder control problems to get help, because the condition is treatable and not all doctors routinely a...

• J&J hopes to avoid felony charge
  According to a Wall Street Journal report, Johnson & Johnson and the U.S. Justice Department are close to settling a lengthy investigation into allegations that the company used illegal tactics in marketing its antipsychotic drug Risperdal. The report cites unnamed sources who said the settlemen...

• Writer says J&J missteps worry investors
  In a recent article, The Motley Fool writer Catherine Baab-Muguira addresses a number of recent management errors and product recalls at Johnson & Johnson. She writes that they’ve “had investors scratching their heads and asking: Is Johnson & Johnson broken?” The Department of Justice ...

• J&J hopes acquisition will help undo some damage
  Johnson & Johnson officials hope the $19.7 billion acquisition of Synthes, which makes surgical trauma equipment and orthopedic implants, will give the company a dominant position in the orthopedic surgery market. According to a Bloomberg report, Johnson & Johnson’s prescription drugs and ...

• J&J reportedly plans $2.2 billion settlement
  Bloomberg reports that Johnson & Johnson has agreed to pay as much as $2.2 billion to settle federal government investigations into claims that the company illegally marketed antipsychotic drug Risperdal and other medications. The report quotes unnamed sources as saying the settlement will inclu...